Clinically relevant drug interactions with multikinase inhibitors: a review

Multikinase inhibitors (MKIs), including the tyrosine kinase inhibitors (TKIs), have rapidly become an established factor in daily (hemato)-oncology practice. Although the oral route of administration offers improved flexibility and convenience for the patient, challenges arise in the use of MKIs. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussaarts, Koen G. A. M., Veerman, G. D. Marijn, Jansman, Frank G. A., van Gelder, Teun, Mathijssen, Ron H. J., van Leeuwen, Roelof W. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322107/
https://www.ncbi.nlm.nih.gov/pubmed/30643582
http://dx.doi.org/10.1177/1758835918818347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322107/
https://www.ncbi.nlm.nih.gov/pubmed/30643582
http://dx.doi.org/10.1177/1758835918818347

Ejemplares similares